Skip To Main Content
of Siena on Muck Rack

of Siena

As seen in: Nature, Annals of the Rheumatic Diseases, Postgraduate Medical Journal, Science Magazine, JACC: Cardiovascular Interventions, Reproductive BioMedicine Online, International Journal of Cardiology, Multiple Sclerosis and Related Disorders, European Journal of Vascular and Endovascular Surgery, Heart, Lung and Circulation
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with of

Contact of, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19

|
By Alessandro Gozzetti, Monica Bocchia, of Siena, Enrico Capochiani
| Nature Verified
Reference Author information Affiliations Division of Hematology, University of Siena, Siena, Italy Alessandro Gozzetti & Monica Bocchia Hematology Unit, Center for Translational Medicine, Azienda USL Toscana NordOvest, Livorno, Italy Enrico Capochiani Corresponding author Correspondence to Alessandro Gozzetti. Ethics declarations Conflict of interest The authors declare that they have no conflict of interest.
Open in Who Shared Issue with article?

COVID-19 and the burning issue of drug interaction: never forget the ECG

|
By Carlotta Sciaccaluga, of Siena, Matteo Cameli, Daniele Menci
| Postgraduate Medical Journal Verified
COVID-19 and the burning issue of drug interaction: never forget the ECG Free http://orcid.org/0000-0002-1965-1773Carlotta Sciaccaluga1, Matteo Cameli1, Daniele Menci1, Giulia Elena Mandoli1, Nicolò Sisti1, Paolo Cameli2, Federico Franchi3, Sergio Mondillo1, Serafina Valente1 1Department of Medical Biotechnologies, Section of Cardiology, University of Siena, Siena, Italy 2Respiratory Diseases and Lung Transplantation, Department of Medicine, Surgery and Neurosciences, Siena University...
Open in Who Shared Issue with article?

High dosage of methylprednisolone as a rescue, second-line treatment in COVID-19 patients who failed to respond to tocilizumab

|
By Edoardo Conticini, Rheumatology Unit, of Siena, Federico Franchi
| Annals of the Rheumatic Diseases Verified
High dosage of methylprednisolone as a rescue, second-line treatment in COVID-19 patients who failed to respond to tocilizumab Free http://orcid.org/0000-0002-3974-6606Edoardo Conticini1, Federico Franchi2, David Bennett3, Serafina Valente4, Maria A Mazzei5, Elena Bargagli3, Luca Volterrani5, Sabino Scolletta2, Bruno Frediani1 1Rheumatology Unit, Department of Medical Sciences, Surgery and Neuroscience, University of Siena, Siena, Italy 2Anesthesia and Intensive Care Unit, Department of...
Open in Who Shared Issue with article?
See all 19 articles